These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7984280)

  • 21. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Bolaños FJ; Schechter LE; Laporte AM; Hamon M; Gozlan H
    Proc West Pharmacol Soc; 1991; 34():387-93. PubMed ID: 1838607
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J; Barnes JM; Towers P; Barnes NM
    Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
    Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
    Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
    Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1A, 5-HT1B, and 5-HT3 receptors in the rat spinal cord.
    Laporte AM; Fattaccini CM; Lombard MC; Chauveau J; Hamon M
    J Neural Transm Gen Sect; 1995; 100(3):207-23. PubMed ID: 8748667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors].
    Koscielniak T; Ponchant M; Laporte AM; Guminski Y; Verge D; Hamon M; Gozlan H
    C R Acad Sci III; 1990; 311(6):231-7. PubMed ID: 2121314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
    Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
    Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
    Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
    Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
    Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.
    Nénonéné EK; Radja F; Carli M; van Gelder NM; Afkhami-Dastjerdian S; Reader TA
    Neurochem Res; 1996 Feb; 21(2):167-76. PubMed ID: 9182242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.
    Cox RF; Meller E; Waszczak BL
    Synapse; 1993 Aug; 14(4):297-304. PubMed ID: 8248853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversible blockade of high-affinity choline uptake in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Vickroy TW; Malphurs WL
    Biochem Pharmacol; 1994 Sep; 48(6):1281-7. PubMed ID: 7945422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
    Miralles A; Ribas C; Olmos G; García-Sevilla JA
    J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.